Recombinant TACSTD2 anticorps (AA 31-274)
Aperçu rapide pour Recombinant TACSTD2 anticorps (AA 31-274) (ABIN7477593)
Antigène
Voir toutes TACSTD2 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 31-274
-
Immunogène
- Recombinant fragment of human TACSTD2 protein (around aa 31-274) (exact sequence is proprietary)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC 1:100-1:200
-
Commentaires
-
Positive Control: Liver: A strong membranous Trop-2 immunostaining should be seen in bile ducts.
Negative Control: Liver: Hepatocytes should not show any Trop-2 immunostaining.
-
Protocole
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
-
- TACSTD2 (Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
-
Autre désignation
- TACSTD2 / Trop-2
-
Sujet
- Cell surface glycoprotein Trop-2, Membrane Component Chromosome 1, Surface Marker 1 (M1S1), Pancreatic Carcinoma Marker Protein GA733-1, TROP2, Tumor-Associated Calcium Signal Transducer 2 (TACSTD2),TACSTD2 / Trop-2 antibody validated for immunohistochemistry on 76 different Normal Tissues
-
UniProt
- P09758
Antigène
-